The purpose of this research study is to find out what effects (good and bad) Vidaza has on
patients with prostate cancer. This investigational drug is not approved by the Food and Drug
Administration (FDA) for the treatment of prostate cancer; however, it is approved in
myelodysplastic syndrome - a bone marrow disease. The pharmaceutical company involved in this
study, Pharmion Corporation, is the manufacturer of Vidaza.
Phase:
Phase 2
Details
Lead Sponsor:
US Oncology Research
Collaborators:
Celgene Corporation University of Southern California